Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Celgene Corp | 25 |
| 2 | Massachusetts Institute of Technology | 25 |
| 3 | Astex Therapeutics Ltd | 21 |
| 4 | Institut National de la Santé et de la Recherche Médicale | 20 |
| 5 | German Cancer Research Center | 19 |
| 6 | The Brigham and Women's Hospital Inc | 17 |
| 7 | The University of Texas System | 15 |
| 8 | University of Southern California | 14 |
| 9 | Harvard University | 13 |
| 10 | The University of Texas at Austin | 13 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61P | Therapeutic activity (drug indications) | 522 |
| 2 | A61K | Medicinal preparations | 511 |
| 3 | C12N | Microorganisms, enzymes | 205 |
| 4 | C12Q | Measuring/testing involving enzymes | 188 |
| 5 | C07K | Peptides | 164 |
| 6 | G01N | Investigating / analysing materials | 121 |
| 7 | C07D | Heterocyclic compounds | 82 |
| 8 | C07H | Sugars and derivatives | 82 |
| 9 | C12Y | Enzyme nomenclature (EC numbers) | 36 |
| 10 | Y02A | Climate change adaptation | 34 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Epigenetics and DNA Methylation | 1 |
| 2 | HIV Research and Treatment | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | James G. Herman | Johns Hopkins University | 4 |
| 2 | Chung S. Yang | Rutgers, The State University of New Jersey | 3 |
| 3 | Gunn Iren Meling | University of Oslo | 3 |
| 4 | Guro E. Lind | Norwegian Cancer Society | 3 |
| 5 | John D. Minna | The University of Texas Southwestern Medical Center | 3 |
| 6 | &NA; | 2 | |
| 7 | Adi F. Gazdar | The University of Texas Southwestern Medical Center | 2 |
| 8 | Andreas Waha | University of Bonn | 1 |
| 9 | Arend Koch | University of Würzburg | 1 |
| 10 | Chang-Lai Hao | Institute of Hematology & Blood Diseases Hospital | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine | 2008 | 953 | HIV Research and Treatment |
| Strategies for reversing drug resistance | 2003 | 357 | Epigenetics and DNA Methylation |
| Mechanisms of metastasis | 2008 | 296 | Cancer Cells and Metastasis |
| Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene | 2001 | 279 | Cancer-related molecular mechanisms research |
| Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes | 2006 | 256 | Epigenetics and DNA Methylation |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the chemical composition of 5-Aza-1-(2-deoxy-beta-D-ribofuranosyl)cytosine?
Which organizations hold the most patents related to this compound?
What are the primary patent classification areas for this compound?
What research topics are associated with published papers on this compound?
How has patent activity for this compound trended in recent years?